Stock Events

Stock Events

Ethos Technologies 

$43.39
303
-$0.23-0.53%Friday 20:00
+$0.14+0.32%Friday 23:47After hours

Statistics

Day High
44.33
Day Low
42.15
52W High
44.99
52W Low
9.45
Volume
1,760,886
Avg. Volume
1,571,932
Mkt Cap
109.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-4.2
-2.83
-1.46
-0.09
Expected EPS
-3.5854
Actual EPS
N/A

Financials

-39,009.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
190,000Revenue
-74.12MNet Income

Analyst Ratings

$30.42Average Price Target
The highest estimate is ⁦40.00⁩.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LIFE. It's not an investment recommendation.
NVIDIA
54
NVDA
Microsoft
34
MSFT
Amazon
32
AMZN
AMD
32
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals competes in the biopharmaceutical space, focusing on immunology and inflammatory diseases, similar to aTyr Pharma's focus on immune modulation for various diseases.
AMGEN
AMGN
Mkt Cap217.9B
Amgen operates in the same biotech space, developing therapies for serious illnesses, including those related to immune system disorders, overlapping with aTyr Pharma's therapeutic areas.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, including inflammatory and respiratory diseases, competing with aTyr Pharma's pipeline.
Biogen
BIIB
Mkt Cap32.49B
Biogen focuses on neurology, autoimmune and hematologic disorders, but its expansion into novel therapeutic areas and biologics can pose competition to aTyr Pharma's novel biologic therapies.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals targets serious diseases with its drugs, including cystic fibrosis, which involves managing inflammation and immune response, areas aTyr Pharma is also exploring.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie works on advanced therapies in immunology, oncology, and virology, including treatments for inflammatory diseases, directly competing with aTyr Pharma's focus on immune modulation.
Novartis
NVS
Mkt Cap268B
Novartis offers a broad range of healthcare products in pharmaceuticals, including treatments for autoimmune diseases and inflammation, making it a competitor in the same therapeutic areas as aTyr Pharma.
Pfizer
PFE
Mkt Cap158.45B
Pfizer's wide range of therapeutic areas, including inflammation and immunology, puts it in direct competition with aTyr Pharma, especially with its focus on innovative treatments for diseases.
Merck
MRK
Mkt Cap356.01B
Merck operates in various therapeutic areas, including immunology, and its research into novel therapies for immune-mediated diseases competes with aTyr Pharma's focus.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca has a diverse portfolio in respiratory, cardiovascular, renal, metabolism, and immunology, including therapies for inflammation and autoimmune diseases, competing with aTyr Pharma's research and development focus.

About

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Show More
CEO
Sanjay S. Shukla
Employees
58
Country
United States
ISIN
US29765A1016
WKN
000A42Q2E

Listings

MU
DE
471A.MU
STU
DE
471A.STU
STU
DE
471.STU
F
DE
471A.F

0 Comments

Share your thoughts

FAQs

What is Ethos Technologies stock price today?▼
The current price of LIFE is $43.39 USD — it has decreased by -0.53% in the past 24 hours. Watch Ethos Technologies stock price performance more closely on the chart.
What is Ethos Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Ethos Technologies stocks are traded under the ticker LIFE.
What is Ethos Technologies market cap?▼
Today Ethos Technologies has the market capitalization of 109.02M
When is the next Ethos Technologies earnings date?▼
Ethos Technologies is going to release the next earnings report on November 5, 2026.
What were Ethos Technologies earnings last quarter?▼
LIFE earnings for the last quarter are -4.4 USD per share, whereas the estimation was -4.86 USD resulting in a +9.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ethos Technologies revenue for the last year?▼
Ethos Technologies revenue for the last year amounts to 190,000 USD.
What is Ethos Technologies net income for the last year?▼
LIFE net income for the last year is -74.12M USD.
How many employees does Ethos Technologies have?▼
As of November 2, 2026, the company has 58 employees.
In which sector is Ethos Technologies located?▼
Ethos Technologies operates in the Health & Wellness sector.
When did Ethos Technologies complete a stock split?▼
The last stock split for Ethos Technologies was on July 1, 2019 with a ratio of 1:14.
Where is Ethos Technologies headquartered?▼
Ethos Technologies is headquartered in SAN DIEGO, United States.